Notably, shifting from hyperglycemia to hypoglycemia, as well as the treatment with empagliflozin, reduced the magnitude of these effects and expression of MyD88 both in MCF7, MDA-MB-231 cells, and AC16 cells. The gene discussed is MYD88; the disease is Hypoglycemia.